Brief: Prelude Therapeutics Reports Full Year 2021 Financial Results
16/03/2022 11:38
March 16 (Reuters) - Prelude Therapeutics Inc PRLD.O :
* PRELUDE THERAPEUTICS REPORTS FULL YEAR 2021 FINANCIAL
RESULTS
* PRELUDE THERAPEUTICS INC - CASH RUNWAY GUIDANCE EXTENDED
TO
2H/2024
Source text for Eikon: ID:nGNX4b05rr
Further company coverage: PRLD.O
Recent news on Prelude Therapeutics Incorporated
See all newsBrief: Prelude Announces Clinical Trial Collaboration And Supply Agreement With Lilly To Evaluate KAT6A Selective Degrader PRT13722 In Combination With Verzenio® And Inluriyo® In Patients With HR+/HER2- Breast Cancer
U.S. RESEARCH ROUNDUP-Celcuity, Fluence Energy, Salesforce
Prelude Therapeutics Incorporated reports results for the quarter ended June 30 - Earnings Summary
Prelude Therapeutics Q2 revenue beats analyst expectations, net loss narrows
Prelude Therapeutics Incorporated expected to post a loss of 20 cents a share - Earnings Preview